CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $498.85 | $200K | 330,823 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −519 | $499.73 | $259K | 330,304 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −361 | $500.84 | $181K | 329,943 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,017 | $502.87 | $511K | 328,926 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,144 | $503.60 | $576K | 327,782 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −964 | $505.03 | $487K | 326,818 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −875 | $505.78 | $443K | 325,943 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −794 | $506.84 | $402K | 325,149 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −506 | $507.68 | $257K | 324,643 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $509.00 | $102K | 324,443 |
| 2026-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 470,910 | ||
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $481.91 | $19K | 333,903 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $483.90 | $97K | 333,703 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −220 | $491.04 | $108K | 333,483 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −140 | $492.72 | $69K | 333,343 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −144 | $493.98 | $71K | 333,199 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $494.87 | $297K | 332,599 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −256 | $495.75 | $127K | 332,343 |
| 2026-09-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −300 | $497.05 | $149K | 332,043 |
Page 39 of 121 · 2,404 trades